Old Web
English
Sign In
Acemap
>
Paper
>
Out-of-pocket costs for PARP inhibitor treatment: Are ovarian cancer patients at risk for financial toxicity?
Out-of-pocket costs for PARP inhibitor treatment: Are ovarian cancer patients at risk for financial toxicity?
2020
Ross F. Harrison
Siqing Fu
Charlotte C Sun
Hui Zhao
K.H. Lu
Sharon H. Giordano
L A Meyer
Keywords:
PARP inhibitor
Toxicity
Ovarian cancer
Internal medicine
Oncology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]